Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Rui Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9928-5373; OpenAlex author ID A5100448402. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer. Co-author DOI 10.1007/s10637-024-01485-5↗
  2. GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer. Co-author DOI 10.1007/s13402-022-00675-8↗
  3. Homogeneous Multiplex Immunoassay for One-Step Pancreatic Cancer Biomarker Evaluation. Co-author DOI 10.1021/acs.analchem.0c03780↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ting Deng · 1 shared paper, 2025 · strength 0.22
  2. Zhi Ji · 1 shared paper, 2025 · strength 0.22
  3. Yi Ba · 1 shared paper, 2025 · strength 0.22
  4. Xiaojun Zhang · 1 shared paper, 2022 · strength 0.15
  5. Xiaoping Zhang · 1 shared paper, 2022 · strength 0.15
  6. Shilong Han · 1 shared paper, 2022 · strength 0.15
  7. Maoquan Li · 1 shared paper, 2022 · strength 0.15
  8. Zili Huang · 1 shared paper, 2020 · strength 0.15
  9. Yi Lv · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.